The TweenVax Trial aims to improve the rates of HPV (human papillomavirus) vaccinations in adolescents. HPV is a virus that can cause cancer, and getting vaccinated can prevent these cancers. TweenVax is a special program designed to boost vaccination rates by educating doctors, parents, and kids about the importance of the HPV vaccine. The study involves different groups of doctors' offices, each trying various methods to see which works best to encourage vaccinations. The goal is to have all shots done by age 13. Currently, only 16% of kids are fully vaccinated by this age. The study will last up to 1 year and involves kids aged 9-12 who haven't yet received the HPV vaccine.
- Study lasts up to 1 year and involves regular doctor visits.
- Includes education for doctors and families to improve vaccination rates.
- Open to kids aged 9-12 who haven't started the HPV vaccine series.